Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) Inventory Average (2021 - 2025)

GeneDx Holdings has reported Inventory Average over the past 5 years, most recently at $12.3 million for Q4 2025.

  • Quarterly results put Inventory Average at $12.3 million for Q4 2025, up 14.47% from a year ago — trailing twelve months through Dec 2025 was $12.3 million (up 14.47% YoY), and the annual figure for FY2025 was $12.3 million, up 26.63%.
  • Inventory Average for Q4 2025 was $12.3 million at GeneDx Holdings, up from $11.3 million in the prior quarter.
  • Over the last five years, Inventory Average for WGSWW hit a ceiling of $42.9 million in Q3 2022 and a floor of $9.1 million in Q4 2023.
  • Median Inventory Average over the past 5 years was $12.3 million (2025), compared with a mean of $20.1 million.
  • Biggest five-year swings in Inventory Average: skyrocketed 42.24% in 2022 and later tumbled 75.66% in 2023.
  • GeneDx Holdings' Inventory Average stood at $32.3 million in 2021, then dropped by 10.51% to $28.9 million in 2022, then crashed by 68.66% to $9.1 million in 2023, then increased by 18.17% to $10.7 million in 2024, then increased by 14.47% to $12.3 million in 2025.
  • The last three reported values for Inventory Average were $12.3 million (Q4 2025), $11.3 million (Q3 2025), and $12.3 million (Q2 2025) per Business Quant data.